Brookstone Capital Management Novartis Ag Transaction History

Brookstone Capital Management

  • $7.5 Billion
  • Q4 2025

A detailed history of Brookstone Capital Management transactions in Novartis Ag stock. As of the latest transaction made, Brookstone Capital Management holds 12,097 shares of NVS stock, worth $1.59 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,097
Previous 12,107 0.08%
Holding current value
$1.59 Million
Previous $1.55 Million 2.51%
% of portfolio
0.02%
Previous 0.02%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026
SELL
$121.8 - $132.39 $1,218 - $1,323
-10 Reduced 0.08%
12,097 $1.59 Million
Q3 2025

Oct 15, 2025
BUY
$113.5 - $129.73 $70,370 - $80,432
620 Added 5.4%
12,107 $1.55 Million
Q2 2025

Jul 30, 2025
SELL
$101.96 - $121.01 $65,254 - $77,446
-640 Reduced 5.28%
11,487 $1.39 Million
Q1 2025

Apr 29, 2025
BUY
$97.14 - $115.57 $21,565 - $25,656
222 Added 1.86%
12,127 $1.35 Million
Q4 2024

Jan 13, 2025
BUY
$96.78 - $117.18 $12,581 - $15,233
130 Added 1.1%
11,905 $1.16 Million
Q3 2024

Oct 08, 2024
SELL
$106.13 - $120.89 $15,388 - $17,529
-145 Reduced 1.22%
11,775 $1.35 Million
Q2 2024

Jul 18, 2024
SELL
$92.57 - $107.37 $84,516 - $98,028
-913 Reduced 7.11%
11,920 $1.27 Million
Q1 2024

Apr 15, 2024
BUY
$95.27 - $108.47 $15,433 - $17,572
162 Added 1.28%
12,833 $1.24 Million
Q4 2023

Jan 11, 2024
BUY
$92.27 - $101.54 $63,112 - $69,453
684 Added 5.71%
12,671 $1.28 Million
Q3 2023

Oct 20, 2023
BUY
$94.73 - $105.13 $14,872 - $16,505
157 Added 1.33%
11,987 $1.22 Million
Q2 2023

Jul 11, 2023
SELL
$92.52 - $104.91 $500,440 - $567,458
-5,409 Reduced 31.38%
11,830 $1.19 Million
Q1 2023

Apr 18, 2023
SELL
$80.03 - $92.81 $85,151 - $98,749
-1,064 Reduced 5.81%
17,239 $1.59 Million
Q4 2022

Jan 09, 2023
SELL
$75.55 - $92.52 $4,986 - $6,106
-66 Reduced 0.36%
18,303 $0
Q3 2022

Oct 13, 2022
SELL
$74.61 - $87.26 $7,311 - $8,551
-98 Reduced 0.53%
18,369 $1.38 Million
Q2 2022

Jul 11, 2022
BUY
$80.52 - $93.75 $564,686 - $657,468
7,013 Added 61.23%
18,467 $1.56 Million
Q1 2022

Apr 12, 2022
SELL
$80.11 - $90.62 $39,173 - $44,313
-489 Reduced 4.09%
11,454 $1.07 Million
Q4 2021

Jan 11, 2022
BUY
$79.7 - $88.13 $121,701 - $134,574
1,527 Added 14.66%
11,943 $1.07 Million
Q3 2021

Nov 03, 2021
BUY
$81.78 - $95.14 $19,790 - $23,023
242 Added 2.38%
10,416 $859,000
Q2 2021

Jul 14, 2021
BUY
$85.24 - $94.15 $178,236 - $196,867
2,091 Added 25.87%
10,174 $943,000
Q1 2021

Apr 16, 2021
BUY
$83.5 - $98.47 $9,769 - $11,520
117 Added 1.47%
8,083 $691,000
Q4 2020

Jan 13, 2021
SELL
$78.07 - $94.43 $6,479 - $7,837
-83 Reduced 1.03%
7,966 $752,000
Q3 2020

Oct 13, 2020
SELL
$82.14 - $91.0 $37,702 - $41,769
-459 Reduced 5.39%
8,049 $700,000
Q2 2020

Jul 21, 2020
BUY
$80.93 - $91.1 $467,613 - $526,375
5,778 Added 211.65%
8,508 $743,000
Q1 2020

Apr 14, 2020
SELL
$70.67 - $99.01 $6,218 - $8,712
-88 Reduced 3.12%
2,730 $225,000
Q4 2019

Jan 29, 2020
BUY
$84.35 - $95.37 $32,390 - $36,622
384 Added 15.78%
2,818 $267,000
Q3 2019

Oct 18, 2019
SELL
$85.54 - $94.26 $12,146 - $13,384
-142 Reduced 5.51%
2,434 $211,000
Q2 2019

Jul 25, 2019
BUY
$75.4 - $92.8 $21,941 - $27,004
291 Added 12.74%
2,576 $235,000
Q1 2019

Apr 18, 2019
SELL
$75.32 - $86.15 $19,357 - $22,140
-257 Reduced 10.11%
2,285 $220,000
Q4 2018

Feb 06, 2019
BUY
$73.66 - $82.02 $187,243 - $208,494
2,542 New
2,542 $218,000
Q2 2018

Aug 06, 2018
SELL
$64.91 - $73.36 $166,169 - $187,801
-2,560 Closed
0 $0
Q1 2018

Apr 23, 2018
SELL
$70.39 - $84.15 $11,543 - $13,800
-164 Reduced 6.02%
2,560 $207,000
Q4 2017

Feb 07, 2018
SELL
$72.33 - $77.64 $20,252 - $21,739
-280 Reduced 9.32%
2,724 $229,000
Q3 2017

Oct 31, 2017
BUY
$74.14 - $77.27 $5,486 - $5,717
74 Added 2.53%
3,004 $258,000
Q2 2017

Aug 08, 2017
BUY
N/A
2,930
2,930 $245,000

Others Institutions Holding NVS

# of Institutions
1,614
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Brookstone Capital Management Portfolio

Follow Brookstone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email